NCT04662268View on ClinicalTrials.gov

Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis

CompletedOBSERVATIONAL
Enrollment

206

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

November 1, 2020

Study Completion Date

November 30, 2020

Conditions
Ischemic Colitis
Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04662268 - Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis | Biotech Hunter | Biotech Hunter